Elias Christoforides

Dr. Elias Christoforides

Biotechnology, Agricultural University of Athens, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2018 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
Elias ChristoforidesElias Christoforides
Elias Christoforides
APAndreas Papaioannou
Andreas Papaioannou
KBKostas Bethanis
Kostas Bethanis
The role of beta-cyclodextrin (β-CD) in cholesterol removal primarily from mammalian cells and secondly from dairy products has been studied thoroughly in recent years. Although the physicochemical characterization of the inclusion compound of cholesterol in β-CD has been achieved by various methods, no crystal structure has been determined so far. We report here the crystal structure of the inclusion compound of cholesterol in β-CD. The inclusion complex crystallizes in the triclinic space group P1 forming head-to-head dimers which are stacked along the c-axis. One well-defined cholesterol molecule ‘axially’ encapsulated inside the β-CD dimer and 22 water molecules that stabilize the complexes in the crystalline state comprise the asymmetric unit of the structure. The dimers are arranged in an intermediate (IM) channel packing mode in the crystal. Moreover, MD simulations, at 300 and 340 K, based on the crystallographically determined coordinates of the complex show that the formed cholesterol/β-CD inclusion compound remains very stable in aqueous solution at both temperatures.

4 August 2012 in Journal of Inclusion Phenomena and Macrocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
KBKostas Bethanis
Kostas Bethanis
PTPavlos Tzamalis
Pavlos Tzamalis
FTFrantzeska Tsorteki
Frantzeska Tsorteki
AKAreti Kokkinou
Areti Kokkinou
Elias ChristoforidesElias Christoforides
Elias Christoforides
DMDimitris Mentzafos
Dimitris Mentzafos

26 March 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KHKYRIAKI HATZIAGAPIOU
KYRIAKI HATZIAGAPIOU
KBKostas Bethanis
Kostas Bethanis
EKEleni THEODORE Koniari
Eleni THEODORE Koniari
Elias ChristoforidesElias Christoforides
Elias Christoforides
ONOlti Nikola
Olti Nikola
George I LambrouGeorge I Lambrou
George I Lambrou
Phytocannabinoids possess anticancer properties, as established in vitro and in vivo. However, they are characterized by high lipophilicity. To improve the properties of cannabidiol (CBD), such as solubility, stability, and bioavailability, CBD inclusion complexes with cyclodextrins (CDs) might be employed, offering targeted, faster, and prolonged CBD release. The aim of the present study is to investigate the in vitro effects of CBD and its inclusion complexes in randomly methylated β-CD (RM-β-CD) and 2-hyroxypropyl-β-CD (HP-β-CD). The enhanced solubility of CBD upon complexation with CDs was examined by phase solubility study, and the structure of the inclusion complexes of CBD in 2,6-di-O-methyl-β-CD (DM-β-CD) and 2,3,6-tri-O-methyl-β-CD (TM-β-CD) was determined by X-ray crystallography. The structural investigation was complemented by molecular dynamics simulations. The cytotoxicity of CBD and its complexes with RM-β-CD and HP-β-CD was tested on two cell lines, the A172 glioblastoma and TE671 rhabdomyosarcoma cell lines. Methylated β-CDs exhibited the best inclusion ability for CBD. A dose-dependent effect of CBD on both cancer cell lines and improved efficacy of the CBD–CDs complexes were verified. Thus, cannabinoids may be considered in future clinical trials beyond their palliative use as possible inhibitors of cancer growth.

26 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Elias ChristoforidesElias Christoforides
Elias Christoforides
AAAthena Andreou
Athena Andreou
APAndreas Papaioannou
Andreas Papaioannou
KBKostas Bethanis
Kostas Bethanis
Piperine (PN), the primary pungent alkaloid in black pepper shows several biological activities such as antioxidant, antimicrobial and anti-cancerogenic effects. Similar to other alkaloids, PN is characterized by poor water solubility. One way to improve its solubility and thus its biological activities is by forming inclusion complexes with suitable cyclodextrins. In this work PN inclusion complexes in native β-cyclodextrin (β-CD), its methylated (randomly methylated (RM-β-CD), heptakis-(2,6-di-O-methyl)-β-CD (DM-β-CD) and heptakis-(2,3,6-tri-O-methyl)-β-CD (TM-β-CD)) and 2-hydroxypropylated (HP-β-CD) derivatives are investigated using physicochemical methods, such as phase solubility study and X-ray crystallography complemented by theoretical (molecular dynamics simulations) studies. The determination of the crystal structure of the PN inclusion complexes in β-CD, DM-β-CD and TM-β-CD, reveals the formation of 1:2 guest:host inclusion complexes in the crystalline state. The guest PN molecule threads the hydrophobic cavities of the hosts which are arranged as couples in a tail-to-tail mode in the case of PN/β-CD and in a head-to-tail mode in the cases of PN/DM-β-CD and PN/TM-β-CD. MD studies based on the crystallographically determined structures and docked models show the stability of the examined complexes in an aqueous environment whereas the binding affinity of PN for the host molecules is calculated by the MM/GBSA method. Finally, phase-solubility studies of PN with β-CD, RM-β-CD and HP-β-CD are presented, indicating a Bs-type for the PN/β-CD complex and an AL-type for the PN/RM-β-CD and PN/HP-β-CD complexes with 1:1 guest:host stoichiometry.


1 June 2018 in Journal of Molecular Structure
Verified
Journal Article
Closed access
KFKaterina Fourtaka
Katerina Fourtaka
Elias ChristoforidesElias Christoforides
Elias Christoforides
DMDimitris Mentzafos
Dimitris Mentzafos
KBKostas Bethanis
Kostas Bethanis